Europa Biosite
Europa Biosite is a privately held, pan-European life science distributor operating in 17 countries across Europe and North America through seven regional subsidiaries, supplying more than 10 million research-use-only reagents and technologies to academic, biotech and pharmaceutical R&D customers.
- Company typePrivate
- Founded-
- HeadquartersTäby, Sweden
- Headcount101–250
- GTM typeB2B
- OfferingServices
What Europa Biosite does
Europa Biosite (legal entity Nordic BioSite Holding AB, company number 559210-7428) is a privately held life science distributor headquartered in Täby, Sweden, operating in 17 countries across Europe and North America through seven wholly-owned regional subsidiaries: Amsbio (USA), Biomol (Germany), Cambridge Bioscience (UK and Ireland), LubioScience (Switzerland), Nordic Biosite (Nordics and Baltics), Sanbio (Benelux) and Szabo-Scandic (Austria), with UK-based Stratech Scientific added in February 2026. The company's core offering is the distribution of more than 10 million research-use-only life science products — reagents, kits and advanced technologies — to academic research institutions, biotechnology companies and pharmaceutical R&D organizations, with all products explicitly labeled for research use only and not for diagnostic or therapeutic use.
The underlying technology is principally the distribution platform itself: a pan-European commercial infrastructure that delivers locally-tailored sales, customer support and regulatory-compliant (GDPR, RUO) handling in each market while aggregating supplier relationships centrally. Recent additions to the portfolio include Ntensify mano and Ntensify micro RNA production technologies and forthcoming Ncapsulate LNP formulation kits from Quantoom Biosciences (partnership announced 17 March 2026), extending the offering into mRNA and lipid nanoparticle workflows.
Revenue is generated through B2B distribution across the subsidiary network under channel-partner commercial arrangements with global life science suppliers; pricing is not publicly disclosed. The company was acquired by EQT Healthcare Growth in July 2025 from Adelis Equity, appointed Claudia Berrón as CEO effective 1 April 2026, and is actively pursuing further acquisitions and supplier partnerships to broaden its technology coverage and geographic footprint.
Europa Biosite firmographics
Firmographics- Name
- Europa Biosite
- Legal name
- Nordic BioSite Holding AB
- Website
- https://europabiosite.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Europa Biosite is a privately held, pan-European life science distributor operating in 17 countries across Europe and North America through seven regional subsidiaries, supplying more than 10 million research-use-only reagents and technologies to academic, biotech and pharmaceutical R&D customers.
- Ownership category
- akta.pro rank
Europa Biosite industry classification
Industry- Product category
- Life Science Distribution
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- Laboratory Apparatus & Furniture (3821), Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Bioprocess Consumables & Reagents (resins, membranes, media components, buffers) (HLAAAJAI)
- akta.pro secondary industry
- mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA) (HLAGAGAC)
Keywords
Where Europa Biosite is headquartered
LocationHeadquarters
- HQ city
- Täby
- HQ country
- Sweden
- HQ region
- Europe
Offices8 records
Markets served
Europa Biosite business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Life Science Product Distribution: Europa Biosite generates revenue through distributing life science reagents and products for healthcare R&D. The company supplies over ten million research-use-only products across 17 countries in Europe and North America. Revenue is derived from sales through its pan-European distribution network to academic, biotech, and pharmaceutical laboratories.
Go-to-market motion2 records
Distribution channels1 record
Marketing channels3 records
Europa Biosite product offering
Product offeringCore offering
Europa Biosite is a pan-European life science product distributor that sources research-use-only reagents, biotechnology tools, and advanced technologies from global manufacturers and resells them to academic, biotechnology, and pharmaceutical customers across 17 countries in Europe and North America. The company operates through locally-based regional subsidiaries (Amsbio, Biomol, Cambridge Bioscience, LubioScience, Nordic Biosite, Sanbio, Szabo-Scandic), distributing over ten million products including emerging RNA production technologies such as Ntensify® mano, Ntensify® micro, and forthcoming Ncapsulate® LNP formulation kits.
Product overview
Europa Biosite is a pan-European life science product distributor that operates as a platform of regional subsidiaries, rather than a single unified product. The company distributes over ten million research-use-only products across 17 countries through its network of regional subsidiaries (Amsbio in USA, Biomol in Germany, Cambridge Bioscience in UK/Ireland, LubioScience in Switzerland, Nordic Biosite in Nordics/Baltics, Sanbio in Benelux, Szabo-Scandic in Austria). Recently, the company has expanded into RNA research technologies through a distribution partnership with Quantoom Biosciences, adding Ntensify® mano, Ntensify® micro, and upcoming Ncapsulate® LNP formulation kits to its portfolio. The company also acquired UK distributor Stratech Scientific in February 2026. Products are explicitly labeled for research use only and are not intended for diagnostic or therapeutic use.
Differentiator
Problem solved
Functional benefit
Products and services
- Ntensify® mano RNA production technology Rapid and qualitative RNA production technology for research settings, manufactured by Quantoom Biosciences and distributed by Europa Biosite across Europe for life science researchers.
- Ntensify® micro RNA production technology Rapid and qualitative RNA production technology for research settings, manufactured by Quantoom Biosciences and distributed by Europa Biosite across Europe for life science researchers.
- Ncapsulate® LNP Formulation Kits LNP (lipid nanoparticle) formulation kits for RNA research, to be distributed by Europa Biosite across Europe as they become available under the partnership with Quantoom Biosciences.
- Pan-European research reagent distribution Distribution of over 10 million research-use-only life science reagents and products to academic, biotechnology, and pharmaceutical laboratories across 17 countries in Europe and North America via locally-based regional subsidiaries.
Quantifiable outcome
- Geographic partnership expansion results in double digit growth
- +2 more outcomes
Companies that use Europa Biosite
Customer profileSegments3 records
Ideal customer profiles4 records
Europa Biosite technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Europa Biosite partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Quantoom BiosciencescoreStrategic distribution partnership where Europa Biosite distributes Quantoom's Ntensify® mano and Ntensify® micro RNA production technologies across Europe. The agreement expands Europa Biosite's portfolio in the rapidly growing RNA research field and is expected to extend to include Ncapsulate® LNP formulation kits as they become available. The partnership aims to make high-quality RNA production and formulation tools more accessible to researchers, accelerating development of next-generation RNA applications and therapeutics.
- Stratech ScientificcoreEuropa Biosite acquired Stratech Scientific through its UK subsidiary Cambridge Bioscience. Stratech Scientific is a well-respected, long-established UK life science distributor known for high quality research reagents and strong supplier partnerships. The acquisition significantly expands Europa Biosite's UK product offering, broadens reach across academic and industrial research communities, and strengthens Cambridge Bioscience's position as a leading partner for UK life science researchers. Integrating Stratech Scientific with Cambridge Bioscience combines complementary portfolios, creating greater choice for UK researchers.
Scale indicators4 records
Recent moves7 records
Expansion highlights5 records
Europa Biosite competitors and assessment
Company assessmentBroad incumbents
- Avantor: Avantor is the largest global life science and laboratory distribution platform following its VWR acquisition; it directly competes with Europa Biosite across European research reagent and lab supplies, and Avantor is also the former employer of Europa Biosite's incoming CEO.
- Thermo Fisher Scientific: Thermo Fisher is the world's largest life science tools and reagents company, competing with Europa Biosite as a one-stop supplier of research reagents, lab consumables, and analytical instruments to academic and biotech customers across Europe and the US.
- Bio-Rad Laboratories: Bio-Rad supplies life science research reagents, clinical diagnostics, and laboratory instruments through a distributor-led model in Europe, overlapping meaningfully with Europa Biosite's research-use reagent and instrument portfolio.
- Cytiva (Danaher): Cytiva is a major supplier of bioprocess consumables, resins, and filtration products, and its products flow through distributors like Europa Biosite's Biomol and Cambridge Bioscience subsidiaries, making it both a partner and competitive reference point in bioprocess distribution.
- Merck KGaA (Life Science / Sigma-Aldrich): Merck's Life Science division, including the Sigma-Aldrich portfolio, is a direct competitor in the distribution of research reagents, bioprocess consumables, and laboratory chemicals to European academic and pharmaceutical customers.
- Revvity (formerly PerkinElmer Life Sciences): Revvity operates life sciences reagents, analytical instruments, and software across academic and pharma research customers, overlapping with Europa Biosite's instrument and reagent distribution business in Europe and the US.
Emerging players
- Bio-Techne: Bio-Techne develops and distributes high-margin research reagents (proteins, antibodies, assays) and relies on European distribution partners - structurally adjacent to Europa Biosite's premium reagent portfolio and a relevant comparable on pricing power.
- Stemcell Technologies: Stemcell Technologies distributes cell culture and research reagents via a network of regional distributors across Europe; it shares Europa Biosite's model of serving academic and biotech researchers with specialized life science products through local sales representation.
- Tecan: Tecan manufactures liquid handling and analytical instruments distributed to academic and pharma research labs; it is both a potential partner brand in Europa Biosite's portfolio and a comparable on European life science distribution economics.
Regional players
- Sarstedt: Sarstedt is a European-headquartered manufacturer and direct distributor of laboratory consumables and sample collection products, overlapping with Europa Biosite's lab consumables and reagent categories across the DACH region.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Europa Biosite compliance and trust
Trust signalCompliance2 records
Europa Biosite financial estimates
Financial estimateRevenue estimate
Valuation estimate
Europa Biosite leadership team
Management profileNumber of profiles
Profiles4 records
Europa Biosite subsidiaries and ownership
Company hierarchySubsidiaries8 records
Europa Biosite funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Europa Biosite M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Europa Biosite
What does Europa Biosite do?
Europa Biosite is a pan-European life science product distributor that sources research-use-only reagents, biotechnology tools, and advanced technologies from global manufacturers and resells them to academic, biotechnology, and pharmaceutical customers across 17 countries in Europe and North America. The company operates through locally-based regional subsidiaries (Amsbio, Biomol, Cambridge Bioscience, LubioScience, Nordic Biosite, Sanbio, Szabo-Scandic), distributing over ten million products including emerging RNA production technologies such as Ntensify® mano, Ntensify® micro, and forthcoming Ncapsulate® LNP formulation kits.
Is Europa Biosite a public or private company?
Europa Biosite is a private company. It is classified as private equity controlled and is currently operating.
When was Europa Biosite founded?
Europa Biosite was founded in -1. It employs 101 to 250 people.
Where is Europa Biosite based?
Europa Biosite is headquartered in Täby, Sweden, in the Europe region.
How does Europa Biosite make money?
One revenue line is on record: life Science Product Distribution.
Who are Europa Biosite's main competitors?
Broad incumbents on record are Avantor, Thermo Fisher Scientific, Bio-Rad Laboratories, Cytiva (Danaher), Merck KGaA (Life Science / Sigma-Aldrich) and Revvity (formerly PerkinElmer Life Sciences). Emerging players are Bio-Techne, Stemcell Technologies and Tecan. Sarstedt is listed as a regional player.
Does Europa Biosite have an API?
No public API is recorded for Europa Biosite.
What industry is Europa Biosite in?
Europa Biosite's product category is Life Science Distribution. Its primary akta.pro industry code is HLAAAJAI, Bioprocess Consumables & Reagents (resins, membranes, media components, buffers), with a secondary code of HLAGAGAC, mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA). Its NAICS code is 334516 and its SIC code is 3821.